Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0

R. Aarnoutse; J. M. P. G. M. de Vos-Geelen; J. Penders; E. G. Boerma; F. A. R. M. Warmerdam; B. Goorts; S. W. M. Olde Damink; Z. Soons; S. S. M. Rensen; M. L. Smidt

doi:10.1007/s00384-017-2819-3

Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0

R. Aarnoutse, J. M. P. G. M. de Vos-Geelen, J. Penders, E. G. Boerma, F. A. R. M. Warmerdam, B. Goorts, S. W. M. Olde Damink, Z. Soons, S. S. M. Rensen, M. L. Smidt^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1077-1084
Number of pages	8
Journal	International Journal of Colorectal Disease
Volume	32
Issue number	7
DOIs	https://doi.org/10.1007/s00384-017-2819-3
Publication status	Published - Jul 2017

Keywords

Intestinal microbiota
Colorectal cancer treatment
RANDOMIZED-TRIAL
CAPECITABINE
CARCINOGENESIS
FLUOROURACIL
CHEMOTHERAPY

Access to Document

10.1007/s00384-017-2819-3

Cite this

Aarnoutse, R., de Vos-Geelen, J. M. P. G. M., Penders, J., Boerma, E. G., Warmerdam, F. A. R. M., Goorts, B., Damink, S. W. M. O., Soons, Z., Rensen, S. S. M., & Smidt, M. L. (2017). Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0. International Journal of Colorectal Disease, 32(7), 1077-1084. https://doi.org/10.1007/s00384-017-2819-3

Aarnoutse, R. ; de Vos-Geelen, J. M. P. G. M. ; Penders, J. ; Boerma, E. G. ; Warmerdam, F. A. R. M. ; Goorts, B. ; Damink, S. W. M. Olde ; Soons, Z. ; Rensen, S. S. M. ; Smidt, M. L. / Study protocol on the role of intestinal microbiota in colorectal cancer treatment : a pathway to personalized medicine 2.0. In: International Journal of Colorectal Disease. 2017 ; Vol. 32, No. 7. pp. 1077-1084.

@article{4dfdc5210d744b5f90e76d44973fee8a,

title = "Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0",

keywords = "Intestinal microbiota, Colorectal cancer treatment, RANDOMIZED-TRIAL, CAPECITABINE, CARCINOGENESIS, FLUOROURACIL, CHEMOTHERAPY",

author = "R. Aarnoutse and {de Vos-Geelen}, {J. M. P. G. M.} and J. Penders and Boerma, {E. G.} and Warmerdam, {F. A. R. M.} and B. Goorts and Damink, {S. W. M. Olde} and Z. Soons and Rensen, {S. S. M.} and Smidt, {M. L.}",

year = "2017",

month = jul,

doi = "10.1007/s00384-017-2819-3",

language = "English",

volume = "32",

pages = "1077--1084",

journal = "International Journal of Colorectal Disease",

issn = "0179-1958",

publisher = "Springer, Cham",

number = "7",

}

Aarnoutse, R , de Vos-Geelen, JMPGM , Penders, J, Boerma, EG, Warmerdam, FARM, Goorts, B, Damink, SWMO , Soons, Z , Rensen, SSM & Smidt, ML 2017, 'Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0', International Journal of Colorectal Disease, vol. 32, no. 7, pp. 1077-1084. https://doi.org/10.1007/s00384-017-2819-3

Study protocol on the role of intestinal microbiota in colorectal cancer treatment : a pathway to personalized medicine 2.0. / Aarnoutse, R.; de Vos-Geelen, J. M. P. G. M.; Penders, J.; Boerma, E. G.; Warmerdam, F. A. R. M.; Goorts, B.; Damink, S. W. M. Olde ; Soons, Z.; Rensen, S. S. M.; Smidt, M. L.

In: International Journal of Colorectal Disease, Vol. 32, No. 7, 07.2017, p. 1077-1084.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Study protocol on the role of intestinal microbiota in colorectal cancer treatment

T2 - a pathway to personalized medicine 2.0

AU - Aarnoutse, R.

AU - de Vos-Geelen, J. M. P. G. M.

AU - Penders, J.

AU - Boerma, E. G.

AU - Warmerdam, F. A. R. M.

AU - Goorts, B.

AU - Damink, S. W. M. Olde

AU - Soons, Z.

AU - Rensen, S. S. M.

AU - Smidt, M. L.

PY - 2017/7

Y1 - 2017/7

KW - Intestinal microbiota

KW - Colorectal cancer treatment

KW - RANDOMIZED-TRIAL

KW - CAPECITABINE

KW - CARCINOGENESIS

KW - FLUOROURACIL

KW - CHEMOTHERAPY

U2 - 10.1007/s00384-017-2819-3

DO - 10.1007/s00384-017-2819-3

M3 - Article

VL - 32

SP - 1077

EP - 1084

JO - International Journal of Colorectal Disease

JF - International Journal of Colorectal Disease

SN - 0179-1958

IS - 7

ER -